Medication Treatment Complexity and Adherence in Children with CKD

被引:37
作者
Blydt-Hansen, Tom D. [1 ]
Pierce, Christopher B.
Cai, Yi
Samsonov, Dmitri
Massengill, Susan
Moxey-Mims, Marva [2 ]
Warady, Bradley A.
Furth, Susan L.
机构
[1] Univ Manitoba, Dept Pediat & Child Hlth, Childrens Hosp, Hlth Sci Ctr,Div Pediat Nephrol, Winnipeg, MB R3A 1S1, Canada
[2] NIDDK, Bethesda, MD 20892 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2014年 / 9卷 / 02期
关键词
CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; RENAL TUBULAR-ACIDOSIS; PILL BURDEN; PATHOGENESIS; PROGRESSION; IMPACT;
D O I
10.2215/CJN.05750513
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
Background and objectives The complexity of CKD management in children is increased by the number of comorbid conditions. This study assessed the prevalence of comorbidities in pediatric CKD and the frequency with which multiple comorbidities present together by assessing prevalent medication use by CKD stage and diagnosis and their association with clinical or sociodemographic factors. The association between number and frequency of dosing of medications prescribed and self-report of nonadherence was also assessed. Design, setting, participants, & measurements In this cross-sectional analysis of the Chronic Kidney Disease in Children study, medication use at study entry grouped by indication was examined by CKD stage, diagnosis, age, race, ethnicity, income, and CKD duration. Multivariate adjusted predictors of medication use and clustering were examined. Nonadherence was assessed by self-report of missed medications in the past 7 days. Results The 558 eligible participants had a median age of 11 years and median GFR of 44 ml/min per 1.73 m(2); 62% of participants were male and 78% had nonglomerular kidney disease. The number of medications for treatment of CKD comorbidities increased with advanced CKD stage (2.5-fold for stages IV versus II; P<0.001) and glomerular disease (1.4-fold versus nonglomerular; P<0.001). Three distinct medication clusters were identified that corresponded to treatment of glomerular disease, advanced renal tubular dysfunction, and proteinuric complications, respectively. Nonadherence was associated with increased medication dosing frequency (administration>2 times/d; P<0.001) but not the number of medications. Conclusions Medical therapy for children with CKD is complex and is affected by glomerular diagnosis, CKD stage, and medication frequency. The need for CKD-related medication treatment cannot be easily predicted by CKD staging alone. Poorer adherence was associated with increased medication frequency, but not with the number of medical problems needing treatment. Consolidating medical treatment and reducing medication frequency may improve adherence rates in children with CKD.
引用
收藏
页码:247 / 254
页数:8
相关论文
共 27 条
[1]
IN-DEPTH REVIEW - DISTAL RENAL TUBULAR-ACIDOSIS - PATHOGENESIS AND CLASSIFICATION [J].
BATLLE, D ;
KURTZMAN, NA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1982, 1 (06) :328-344
[2]
HYPERKALEMIC DISTAL RENAL TUBULAR-ACIDOSIS ASSOCIATED WITH OBSTRUCTIVE UROPATHY [J].
BATLLE, DC ;
ARRUDA, JAL ;
KURTZMAN, NA .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (07) :373-380
[3]
Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppression [J].
Boyle, Brian A. ;
Jayaweera, Dushyantha ;
Witt, Mallory D. ;
Mm, Kristy Gri ;
Maa, Jen-Fue ;
Seekins, Daniel W. .
HIV CLINICAL TRIALS, 2008, 9 (03) :164-176
[4]
Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients [J].
Buscher, A. ;
Hartman, C. ;
Kellen, M. A. ;
Giordano, T. P. .
INTERNATIONAL JOURNAL OF STD & AIDS, 2012, 23 (05) :351-355
[5]
Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis Patients [J].
Chiu, Yi-Wen ;
Teitelbaum, Isaac ;
Misra, Madhukar ;
de Leon, Essel Marie ;
Adzize, Tochi ;
Mehrotra, Rajnish .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (06) :1089-1096
[6]
Progression in chronic kidney disease [J].
Eddy, AA .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2005, 12 (04) :353-365
[7]
EDDY AA, 1994, J AM SOC NEPHROL, V5, P1273
[8]
Frishman William H, 2007, Cardiol Rev, V15, P257, DOI 10.1097/CRD.0b013e3180cabbe7
[9]
Design and methods of the chronic kidney disease in children (CKiD) prospective cohort study [J].
Furth, Susan L. ;
Cole, Stephen R. ;
Moxey-Mims, Marva ;
Kaskel, Frederick ;
Mak, Robert ;
Schwartz, George ;
Wong, Craig ;
Munoz, Alvaro ;
Warady, Bradley A. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (05) :1006-1015
[10]
Using quantile regression to investigate racial disparities in medication non-adherence [J].
Gebregziabher, Mulugeta ;
Lynch, Cheryl P. ;
Mueller, Martina ;
Gilbert, Gregory E. ;
Echols, Carrae ;
Zhao, Yumin ;
Egede, Leonard E. .
BMC MEDICAL RESEARCH METHODOLOGY, 2011, 11